Main Article Content
Haemodynamic and anaesthetic advantages of dexmedetomidine
Abstract
Design: A simple descriptive study.
Settings and subjects: The study was conducted in a tertiary hospital in India from June 2010-June 2011. The 81 American Society of Anesthesiologists classification I and II patients who were enrolled in the study were given a loading dose of dexmedetomidine 1 μg/kg, followed by a continuous infusion of 0.5 μg/kg/hour. Supplementation with end-tidal sevoflurane 1-2% was considered when heart rate (HR) and mean arterial pressure exceeded 20% of baseline values. On completion of surgery, the time taken to discontinue dexmedetomidine infusion and the extubation time were recorded.
Outcome measures: Changes in haemodynamic variables from baseline and a comparison of means were analysed by paired t-test for each time interval.
Results: There was significant reduction in HR and systolic blood pressure following the loading dose of dexmedetomidine (12.31% and 8.82% respectively), in the intraoperative period (17.71% and 16.5% respectively), and during intubation and extubation (p-value < 0.001). None of the patients required supplementary doses of analgesics in the intraoperative period. Only 13 patients required end-tidal sevoflurane of 1% during the study. Seventy per cent of patients could be extubated within five minutes of discontinuing the infusion.
Conclusion: Dexmedetomidine provided a stable haemodynamic profile in the perioperative period and a blunted pressor response to intubation and extubation. With its use, there was a minimal requirement for analgesics and inhalational agents. It had an acceptable recovery profile.
Keywords: intravenous anaesthetics, dexmedetomidine, extubation, haemodynamic stability, intubation, recovery
South Afr J Anaesth Analg 2012;18(6):326-331